Literature DB >> 5420176

Combined thyroxine and triiodothyronine for thyroid replacement therapy.

S Taylor, M Kapur, R Adie.   

Abstract

Tablets containing 50mug. of thyroxine and 15mug. of triiodothyronine have been used to treat patients with hypothyroidism of varied aetiology. Following total thyroidectomy a daily dose of three tablets-that is, 150mug. of thyroxine and 45mug. of triiodothyronine-maintained patients in a euthyroid state and produced a protein-bound iodine level within the normal range. The preparation is preferable to dried thyroid because of uniformity of activity and speed of action, and when the patient is clinically euthyroid the P.B.I. falls within the normal range.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5420176      PMCID: PMC1700438          DOI: 10.1136/bmj.2.5704.270

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  ANOMALOUS EFFECTS OF CERTAIN PREPARATIONS OF DESICCATED THYROID ON SERUM PROTEIN-BOUND IODINE.

Authors:  L E BRAVERMAN; S H INGBAR
Journal:  N Engl J Med       Date:  1964-02-27       Impact factor: 91.245

2.  DETERMINATION OF THYROXINE AND TRIIODOTHYRONINE IN COMMERCIAL PREPARATIONS OF DESICCATED THYROID AND THYROID EXTRACT.

Authors:  V J PILEGGI; O J GOLUB; N D LEE
Journal:  J Clin Endocrinol Metab       Date:  1965-07       Impact factor: 5.958

3.  Effect of triiodothyronine administration on serum PBI in hypothyroid patients maintained on constant doses of thyroxine.

Authors:  T A Farmer; T C Smitherman; R J Beschi; J A Pittman
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

4.  Physiologic combinations of synthetic thyroid hormones in myxedema.

Authors:  M S Wool; H A Selenkow
Journal:  Clin Pharmacol Ther       Date:  1965 Nov-Dec       Impact factor: 6.875

  4 in total
  16 in total

1.  Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone.

Authors:  Tom Rodriguez; Victor R Lavis; Janet C Meininger; Asha S Kapadia; Linda F Stafford
Journal:  Endocr Pract       Date:  2005 Jul-Aug       Impact factor: 3.443

2.  Combined triiodothyronine and thyroxine.

Authors:  R N Smith; S A Taylor; J C Massey
Journal:  Br Med J       Date:  1971-01-02

Review 3.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

4.  The T 4 -free thyroxine index as a test of thyroid function of first choice.

Authors:  P J Howorth; R L Ward
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

5.  Brain Fog in Hypothyroidism: Understanding the Patient's Perspective.

Authors:  Matthew D Ettleson; Ava Raine; Alice Batistuzzo; Samuel P Batista; Elizabeth McAninch; Maria Cristina T V Teixeira; Jacqueline Jonklaas; Neda Laiteerapong; Miriam O Ribeiro; Antonio C Bianco
Journal:  Endocr Pract       Date:  2021-12-08       Impact factor: 3.701

6.  Treatment of hypothyroidism: a reappraisal of thyroxine therapy.

Authors:  D Evered; E T Young; B J Ormston; R Menzies; P A Smith; R Hall
Journal:  Br Med J       Date:  1973-07-21

Review 7.  Scope and limitations of iodothyronine deiodinases in hypothyroidism.

Authors:  Balázs Gereben; Elizabeth A McAninch; Miriam O Ribeiro; Antonio C Bianco
Journal:  Nat Rev Endocrinol       Date:  2015-09-29       Impact factor: 43.330

8.  Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism.

Authors:  R N Smith; S A Taylor; J C Massey
Journal:  Br Med J       Date:  1970-10-17

9.  Liothyronine and levothyroxine prescribing in England: A comprehensive survey and evaluation.

Authors:  Mike Stedman; Peter Taylor; Lakdasa Premawardhana; Onyebuchi Okosieme; Colin Dayan; Adrian H Heald
Journal:  Int J Clin Pract       Date:  2021-07-06       Impact factor: 3.149

Review 10.  Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.

Authors:  James V Hennessey; Ramon Espaillat
Journal:  Int J Clin Pract       Date:  2018-01-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.